2024 Statement from Asia expert operators on transcatheter pulmonary valve replacement.

Autor: Pan W; Zhongshan Hopital, Fudan University, Shanghai, China., Zhou D; Zhongshan Hopital, Fudan University, Shanghai, China., Hijazi ZM; Pediatrics & Medicine, Weill Cornell Medicine, Doha, Qatar., Qureshi SA; Evelina London Children's Healthcare, London, UK., Promphan W; Queen Sirikit National Institute of Child Health, Bangkok, Thailand., Feng Y; West China Hospital, Sichuan University, Chengdu, China., Zhang G; Beijing Fuwai Hospital, Beijing, China., Liu X; Second Hospital of Zhejiang Medical University, Hangzhou, China., Pan X; Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China., Chen L; Union Hospital Fujian Medical University, Fuzhou, China., Cao Q; Sidra Medicine, Doha, Qatar., Tiong KG; Serdang Hospital, Puchong, Malaysia., Leong MC; IJN Hospital, Kuala Lumpur, Malaysia., Roymanee S; PSU Hospital, Hat Yai, Thailand., Prachasilchai P; Queen Sirikit National Institute of Child Health, Pediatric Cardiac Center, Thailand., Choi JY; Severance Hospital, Seodaemun-gu, Korea., Tomita H; Showa University Hospital, Yokohama, Japan., Le Tan J; National Heart Center, Singapore, Singapore., Akhtar K; Armed Forces Institute of Cardiology National Institute of Heart Diseases, Rawalpindi, Pakistan., Lam S; Queen Marry Hospital, Hong Kong, China., So K; The Chinese University of Hong Kong, Hong Kong, China., Tin DN; Children's Hospital, Hanoi, Vietnam., Nguyen LH; Bach Mai Hospital, Hanoi, Vietnam., Huo Y; Peking University First Hospital, Beijing, China., Wang J; Second Hospital of Zhejiang Medical University, Hangzhou, China., Ge J; Zhongshan Hopital, Fudan University, Shanghai, China.
Jazyk: angličtina
Zdroj: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2024 Mar; Vol. 103 (4), pp. 660-669. Date of Electronic Publication: 2024 Feb 28.
DOI: 10.1002/ccd.30978
Abstrakt: Transcatheter pulmonary valve replacement (TPVR), also known as percutaneous pulmonary valve implantation, refers to a minimally invasive technique that replaces the pulmonary valve by delivering an artificial pulmonary prosthesis through a catheter into the diseased pulmonary valve under the guidance of X-ray and/or echocardiogram while the heart is still beating not arrested. In recent years, TPVR has achieved remarkable progress in device development, evidence-based medicine proof and clinical experience. To update the knowledge of TPVR in a timely fashion, and according to the latest research and further facilitate the standardized and healthy development of TPVR in Asia, we have updated this consensus statement. After systematical review of the relevant literature with an in-depth analysis of eight main issues, we finally established eight core viewpoints, including indication recommendation, device selection, perioperative evaluation, procedure precautions, and prevention and treatment of complications.
(© 2024 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: